Leupromak 22.5 mg Injection 1's belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists primarily used to treat prostate cancer and endometriosis. Additionally, it is also used to treat precocious puberty (early puberty) in children. Leupromak 22.5 mg Injection 1's is used in combination with other medicines to treat anaemia caused by uterine fibroids.

Leupromak 22.5 mg Injection 1's contains Leuprolide acetate, which is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. It works by inhibiting the synthesis of the natural male hormone, testosterone in men and oestrogen in women. This process of lowering hormone levels can decrease cancer cell growth in prostate cancer and helps treat endometriosis.

Leupromak 22.5 mg Injection 1's will be administered by a healthcare professional. The common side effects of Leupromak 22.5 mg Injection 1's include hot flashes, decreased sexual interest, dizziness, headache, nausea, vomiting, diarrhoea, upset stomach and injection site reaction. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.

Avoid taking Leupromak 22.5 mg Injection 1's if you are pregnant or breastfeeding. Both women and men using Leupromak 22.5 mg Injection 1's should use effective contraception. Leupromak 22.5 mg Injection 1's may affect fertility, hence discuss with your doctor if you have any plans to start a family in the future. Leupromak 22.5 mg Injection 1's is not recommended for children below two years of age. Leupromak 22.5 mg Injection 1's may cause dizziness, hence drive only if you are alert.

Leupromak 22.5 mg Injection 1's is used in the treatment of Prostate cancer, Endometriosis, and Precocious puberty. The detailed uses of Leupromak 22.5 mg Injection 1's are as follows:

• Treat advanced prostate cancer: Leupromak 22.5 mg Injection 1's is primarily used to manage symptoms of advanced prostate cancer by lowering testosterone levels, which slows the growth of cancer cells.
• Manage endometriosis and uterine fibroids: Leupromak 22.5 mg Injection 1's helps reduce estrogen production, alleviating pain and other symptoms associated with endometriosis and fibroids, and may be used preoperatively to shrink fibroid size.
• Treat central precocious puberty (CPP): Leupromak 22.5 mg Injection 1's is prescribed for children with CPP to delay early onset of puberty and normalize growth and sexual development.
• Support fertility treatments and hormone regulation: Leupromak 22.5 mg Injection 1's is used in assisted reproductive technologies to control hormone levels and prevent premature ovulation during fertility procedures.
• Treat anemia caused by uterine fibroids: In combination with other medications, Leupromak 22.5 mg Injection 1's helps improve hemoglobin levels by reducing menstrual bleeding linked to fibroids.

• Follow your doctor's recommendations on the dosage and timing of this medication to achieve optimal results.
• Leupromak 22.5 mg Injection 1's will be administered by a healthcare professional.
• Do not self-administer.

Leupromak 22.5 mg Injection 1's contains Leuprolide acetate, a gonadotropin-releasing hormone (GnRH) agonist. It treats prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Leupromak 22.5 mg Injection 1's is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. Leupromak 22.5 mg Injection 1's works by lowering testosterone levels in men that help stop the growth of cancer cells in prostate cancer. Leupromak 22.5 mg Injection 1's reduces oestrogen (a hormone required for the development and regulation of the female reproductive system and secondary sexual characteristics) levels in women, thus helping in endometriosis.

If you are allergic to Leupromak 22.5 mg Injection 1's or any other medicines, please tell your doctor. Leupromak 22.5 mg Injection 1's is not indicated for use in pregnancy and breastfeeding women. If you are using Leupromak 22.5 mg Injection 1's, make sure to use reliable forms of contraception. Leupromak 22.5 mg Injection 1's may also affect fertility in men, hence discuss with your doctor if you have any plans to start a family in the future. Leupromak 22.5 mg Injection 1's is not recommended for children younger than two years of age. If you have a seizure or unusual changes in mood or behaviour, inform your doctor immediately. Before starting Leupromak 22.5 mg Injection 1's, let your doctor know if you have liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Leupromak 22.5 mg Injection 1's may cause QT prolongation (heart muscle takes longer than normal to recharge between beats) and may affect heart rhythm, hence heart patients should be cautious while taking Leupromak 22.5 mg Injection 1's. Leupromak 22.5 mg Injection 1's can make you feel dizzy and affects your mental ability to drive. Do not drive or operate machinery if you are not mentally alert and focused.